← Leaderboards
Ziva D Cooper
University Of California Los Angeles
$11,236,541
Attributed
$11,813,629
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,813,629 · 7
By mechanism
R01$10,188,434 · 4
K01$929,462 · 1
R21$695,733 · 2
Top collaborators
- Caroline A Arout2 shared
- Richard W Foltin1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Brigitte L Kieffer$7,782,629
- Michael D Roth$8,922,704
- Ian Alfredo Mendez$644,305
- David Eisenberg$31,979,624
- Patrick Allard$8,147,237
Others in their field
Top investigators on “Tetrahydrocannabinol”
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$15,488,412
- Deepak Cyril D'souza · Va Connecticut Healthcare System$14,296,094
- Jenny L. Wiley · Virginia Commonwealth University$12,923,553
- Elsohly Mahmoud A. · University Of Mississippi$10,595,473
- L. Cinnamon Bidwell · University Of Colorado$9,765,766
- Mahesh Mohan · Tulane University Of Louisiana$9,397,157
Research focus
TetrahydrocannabinolDoseSmokeCannabisDrug KineticsDouble-Blind MethodPre-ClinicalAnalgesicsPainPlacebosAbsence Of Pain SensationCannabinoidsResponseReportingPublic HealthIntoxicationBehavioralPharmaceutical PreparationsPlasmaLaboratory StudyDesignEpidemiologyLaboratoriesSelf Administration
Grant awards (25)
Age-and sex-dependent pharmacodynamics and pharmacokinetics of oral and smoked delta-9-THC$655,198
R01 · FY2025 · DA · contact PI
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and Ã-caryophyllene$630,506
R01 · FY2025 · AT · contact PI
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and Ã-caryophyllene$81,860
R01 · FY2025 · AT · contact PI
Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women$706,259
R01 · FY2024 · DA · contact PI
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and Ã-caryophyllene$68,861
R01 · FY2024 · AT · contact PI
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and Ã-caryophyllene$741,560
R01 · FY2023 · AT · contact PI
Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women$709,018
R01 · FY2023 · DA · contact PI
Age-and sex-dependent pharmacodynamics and pharmacokinetics of oral and smoked delta-9-THC$661,918
R01 · FY2023 · DA · contact PI
Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women$49,785
R01 · FY2023 · DA · contact PI
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and Ã-caryophyllene$761,793
R01 · FY2022 · AT · contact PI
Age-and sex-dependent pharmacodynamics and pharmacokinetics of oral and smoked delta-9-THC$677,487
R01 · FY2022 · DA · contact PI
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and Ã-caryophyllene$804,904
R01 · FY2021 · AT · contact PI
Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women$658,757
R01 · FY2021 · DA · contact PI
Analgesic and subjective effects of terpenes administered alone and in combination with THC: Potential THC- and opioid-sparing effects of myrcene and Ã-caryophyllene$861,211
R01 · FY2020 · AT · contact PI
Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women$669,194
R01 · FY2020 · DA · contact PI
Sex-dependent effects of cannabis: Assessing abuse-related and pharmacokinetic differences between men and women$741,447
R01 · FY2019 · DA · contact PI
Impact of vaporized cannabis with varying cannabidiol and THC ratios on opioid abuse-liability and analgesia$202,500
R21 · FY2019 · DA
Impact of vaporized cannabis with varying cannabidiol and THC ratios on opioid abuse-liability and analgesia$243,000
R21 · FY2018 · DA · contact PI
Preclinical Synthetic Cannabinoid Vapor Inhalation: Acute and Chronic Effects$708,676
R01 · FY2015 · DA · contact PI
Synthesis of Smokable Synthetic Cannabinoids ('Spice') for Human Study$250,233
R21 · FY2014 · DA · contact PI
Behavioral and Physiological Effects of Marijuana on Smoked Cocaine$185,896
K01 · FY2014 · DA · contact PI
Behavioral and Physiological Effects of Marijuana on Smoked Cocaine$185,896
K01 · FY2013 · DA · contact PI
Behavioral and Physiological Effects of Marijuana on Smoked Cocaine$185,896
K01 · FY2012 · DA · contact PI
Behavioral and Physiological Effects of Marijuana on Smoked Cocaine$185,897
K01 · FY2011 · DA · contact PI
Behavioral and Physiological Effects of Marijuana on Smoked Cocaine$185,877
K01 · FY2010 · DA · contact PI